Publication | Closed Access

The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development

Structure-based AssessmentMedicinal ChemistryDrug PurityBioanalysisAnalytical ChemistryToxicologyGenotoxic ImpuritiesChromatographyPredictive ToxicologyBiochemistryPreclinical Drug EvaluationPharmacologyNatural SciencesDrug DiscoveryForensic ToxicologyMedicineActive Pharmaceutical IngredientsPharmaceutical ResearchDrug Analysis